MedPath
HSA Approval

XYLOTIN 50 - Lidocaine Hydrochloride INJECTION USP 50MG/5ML

SIN15952P

XYLOTIN 50 - Lidocaine Hydrochloride INJECTION USP 50MG/5ML

XYLOTIN 50 - Lidocaine Hydrochloride INJECTION USP 50MG/5ML

June 12, 2020

HETERO SINGAPORE PTE. LTD.

HETERO SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantHETERO SINGAPORE PTE. LTD.
Licence HolderHETERO SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

N01BB02

lidocaine

Manufacturer Information

HETERO SINGAPORE PTE. LTD.

Aspiro Pharma Limited

Active Ingredients

Lidocaine Hydrochloride

50mg/5ml

Lidocaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.